Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Biplane Simpson EF

Biplane Simpson EF: LV ejection fraction from apical 2- and 4-chamber disk summation method.

Formula

EF = (avg EDV − avg ESV) / avg EDV × 100%

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Primary LV systolic function assessment on transthoracic echo
HF diagnosis and severity stratification
Post-MI LV function assessment
Cardiotoxicity monitoring (chemotherapy, HER2 inhibitors)
Serial monitoring in LVAD candidates
More accurate than M-mode (Teichholz) in most patients

Key Advantages

Less dependent on geometric assumptions vs. M-mode
Validated against cardiac MRI gold standard
Incorporates regional function variations
Recommended by ESC/AHA guidelines as primary measurement
Reproducible across operators with good image quality

How it Works

Calculation Methodology

Requires apical 2-chamber and 4-chamber views
Tracings of LV endocardium in diastole and systole
LV volume = Σ cylinder volumes stacked base-to-apex
Formula: EF = (EDV − ESV) / EDV × 100%
Biplane method averages 2- and 4-chamber calculations

LV EF Classification

LVEF (%)ClassificationClinical Correlate
>50NormalNo LV dysfunction
41–49Mildly ReducedHFmrEF (newer category)
31–40Moderately ReducedHFrEF (may be symptomatic)
≤30Severely ReducedHFrEF; high risk; LVAD/transplant candidate

Clinical Pearls

Technical Considerations

Image quality critical; foreshortened views → artifactually low EF
Apical thrombus can be included accidentally; visual assessment essential
Paradoxical septal motion (post-cardiac surgery) affects accuracy
Normal EF does NOT exclude diastolic dysfunction or HFpEF
Serial EF drop >5% during chemotherapy warrants intervention

Clinical Pitfalls

Foreshortened apical 4-chamber overestimates EF
Excessive papillary muscle inclusion underestimates volumes
Young athlete physiology (eccentric LV hypertrophy) may lower EF slightly
Tachycardia / arrhythmia reduces reproducibility; average multiple beats

Next Steps

LVEF >50% (Normal)

Normal LV systolic function; reassess if new symptoms
Assess diastolic function if dyspnoea present
Standard follow-up based on clinical indication

LVEF 41–49% (Mildly Reduced / HFmrEF)

Offers risk for HF progression; optimize BP/HR
Consider SGLT2i therapy per recent guidelines
Annual echo surveillance
Identify and treat reversible causes

LVEF 31–40% (Moderately Reduced)

HFrEF diagnosis; initiate quadruple therapy: ACEi/ARB, β-blocker, MRA, SGLT2i
ICD evaluation if EF expected to remain ≤35% after 40 days therapy
CRT consideration if QRS ≥120 ms + symptoms
3–6 month repeat echo after therapy initiation

LVEF ≤30% (Severely Reduced)

High-risk HFrEF; aggressive pharmacotherapy + device therapy
ICD indicated for primary prevention if stable >40 days
Urgent cardiology consultation; evaluate LVAD/transplant candidacy
Monthly clinical monitoring; repeat echo every 3–6 months

Complementary Calculators

TAPSE (RV Systolic Function)
LV Mass Index
AVA (Continuity Equation)
EROA (PISA Method)
MVA (Pressure Half-Time)

The Evidence

Validation

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Lang RM et al. • J Am Soc Echocardiogr.. 2015;e1-39. The landmark guideline for EF quantification.

Origins & History

Development

Biplane Simpson method has become the standard echocardiographic LV function assessment since the 1990s. Formalized in ASE guideline documents; now universal in echo labs worldwide.

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Primary LV systolic function assessment on transthoracic echo
HF diagnosis and severity stratification
Post-MI LV function assessment
Cardiotoxicity monitoring (chemotherapy, HER2 inhibitors)
Serial monitoring in LVAD candidates
More accurate than M-mode (Teichholz) in most patients

Key Advantages

Less dependent on geometric assumptions vs. M-mode
Validated against cardiac MRI gold standard
Incorporates regional function variations
Recommended by ESC/AHA guidelines as primary measurement
Reproducible across operators with good image quality

How it Works

Calculation Methodology

Requires apical 2-chamber and 4-chamber views
Tracings of LV endocardium in diastole and systole
LV volume = Σ cylinder volumes stacked base-to-apex
Formula: EF = (EDV − ESV) / EDV × 100%
Biplane method averages 2- and 4-chamber calculations

LV EF Classification

LVEF (%)ClassificationClinical Correlate
>50NormalNo LV dysfunction
41–49Mildly ReducedHFmrEF (newer category)
31–40Moderately ReducedHFrEF (may be symptomatic)
≤30Severely ReducedHFrEF; high risk; LVAD/transplant candidate

Clinical Pearls

Technical Considerations

Image quality critical; foreshortened views → artifactually low EF
Apical thrombus can be included accidentally; visual assessment essential
Paradoxical septal motion (post-cardiac surgery) affects accuracy
Normal EF does NOT exclude diastolic dysfunction or HFpEF
Serial EF drop >5% during chemotherapy warrants intervention

Clinical Pitfalls

Foreshortened apical 4-chamber overestimates EF
Excessive papillary muscle inclusion underestimates volumes
Young athlete physiology (eccentric LV hypertrophy) may lower EF slightly
Tachycardia / arrhythmia reduces reproducibility; average multiple beats

Next Steps

LVEF >50% (Normal)

Normal LV systolic function; reassess if new symptoms
Assess diastolic function if dyspnoea present
Standard follow-up based on clinical indication

LVEF 41–49% (Mildly Reduced / HFmrEF)

Offers risk for HF progression; optimize BP/HR
Consider SGLT2i therapy per recent guidelines
Annual echo surveillance
Identify and treat reversible causes

LVEF 31–40% (Moderately Reduced)

HFrEF diagnosis; initiate quadruple therapy: ACEi/ARB, β-blocker, MRA, SGLT2i
ICD evaluation if EF expected to remain ≤35% after 40 days therapy
CRT consideration if QRS ≥120 ms + symptoms
3–6 month repeat echo after therapy initiation

LVEF ≤30% (Severely Reduced)

High-risk HFrEF; aggressive pharmacotherapy + device therapy
ICD indicated for primary prevention if stable >40 days
Urgent cardiology consultation; evaluate LVAD/transplant candidacy
Monthly clinical monitoring; repeat echo every 3–6 months

Complementary Calculators

TAPSE (RV Systolic Function)
LV Mass Index
AVA (Continuity Equation)
EROA (PISA Method)
MVA (Pressure Half-Time)

The Evidence

Validation

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Lang RM et al. • J Am Soc Echocardiogr.. 2015;e1-39. The landmark guideline for EF quantification.

Origins & History

Development

Biplane Simpson method has become the standard echocardiographic LV function assessment since the 1990s. Formalized in ASE guideline documents; now universal in echo labs worldwide.

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this has broad domain relevance to Biplane Simpson EF.

WHO NewsJul 15, 2026
Global childhood immunization coverage inches forward despite conflict and hesitancy – UNICEF, WHO

Clinical Context

We think this has broad domain relevance to Biplane Simpson EF.

WHO NewsJul 15, 2026
New WHO guidelines: up to 45% of dementia risk could be prevented or delayed

Clinical Context

We think this has broad domain relevance to Biplane Simpson EF.